glp 1 mash approval FDA Expands Novo Nordisk's Wegovy to the Fatty Liver Disease Novo Nordisk leads MASH therapeutic

Frequently Asked Questions Can you reduce food noise without taking GLP-1 medications

But they were built for different goals and different audiences

Adequate protein intake during weight loss reduces but may not eliminate this effect

The advice applies to occasional schedule adjustments, not a pattern of shortening your injection interval

Am J Physiol Physiol 297(6):F1647F1655 Meier JJ (2012) GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

We don't have good data on: *What outcomes look like at various sub-therapeutic doses *Which patients might benefit from lower, more frequent dosing versus higher, less frequent *How hormonal changes (hello, perimenopause) affect optimal dosing *Long-term effects of maintenance microdosing after weight loss goals are met The doctor quoted in the article is right that standard doses exist because they've been proven effective